The Now (The Now) EBIT : $-17.77 Mil (TTM As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is The Now EBIT?

The Now's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2015 was $0.00 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2015 was $-17.77 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. The Now's annualized ROC % for the quarter that ended in Sep. 2015 was 0.00%. The Now's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2015 was 0.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. The Now's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2015 was -6,301.06%.

The Now EBIT Historical Data

The historical data trend for The Now's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Now EBIT Chart

The Now Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

EBIT

Get a 7-Day Free Trial

-0.35

-36.91

-119.86

-99.12

-48.84

The Now Quarterly Data
	Dec07	Dec08	Dec09	Dec10	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Sep14	Sep15
EBIT	Get a 7-Day Free Trial											-19.78	-7.82	-9.92	-0.02	-

Competitive Comparison of The Now's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, The Now's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Now's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Now's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where The Now's EV-to-EBIT falls into.

The Now EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.77 Mil.

The Now (OTCPK:NWPN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

The Now's annualized ROC % for the quarter that ended in Sep. 2015 is calculated as:

	ROC % (Q: Sep. 2015 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2014 )	+	Invested Capital (Q: Sep. 2015 ))	/ count )
=	0 * ( 1 - 0% )	/	( (0	+	0.915)	/ 1 )
=	0	/	0.915
=	0.00 %

where

	Invested Capital		(Q: Sep. 2014 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0	-	0	-	( 0	-	max(0, 0	-	0	+	0	))
=	0

	Invested Capital		(Q: Sep. 2015 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.042	-	0.141	-	( 0	-	max(0, 1.014	-	0	+	0	))
=	0.915

Note: The Operating Income data used here is four times the quarterly (Sep. 2015) data.

2. Joel Greenblatt's definition of Return on Capital:

The Now's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2015 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2015 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2014		Q: Sep. 2015
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	0	/	( ( (0 + max(0, 0))	+	(0.042 + max(-0.788, 0)) )	/	1 )
=	0	/	( ( 0	+	0.042 )	/	1 )
=	0	/	0.042
=	0.00 %

where Working Capital is:

	Working Capital		(Q: Sep. 2014 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0	+	0	+	0)
=	0

	Working Capital		(Q: Sep. 2015 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(0.141	+	0	+	0.647)
=	-0.788

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2015) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

The Now's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2015 )
	=	-17.769	/	0.282
	=	-6,301.06 %

The Now EBIT Related Terms

Thank you for viewing the detailed overview of The Now's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

The Now (The Now) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Now Corp (OTCPK:NWPN) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

3400 Pan American Drive, Unit 53, Miami, FL, USA, 33133

Website

https://www.thenowcorp.net

The Now Corp is a biopharmaceutical research company. The company focused on the research, education, and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purposes. It provides Credible Scientific Research Data to the heavily regulated medical and recreational marijuana industries.

The Now (The Now) Headlines

From GuruFocus

The Now Corporation (OTC: NWPN) Ignites the African Gold Industry with a Game-Changing Acquisition

By ACCESSWIRE • 07-20-2023